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Abstract Meltrin L (ADAM19) is a metalloprotease-disinte-
grin expressed in the peripheral nervous system and other or-
gans during embryogenesis. We report here an alternatively
spliced isoform, meltrin L mini, that lacks the prodomain, metal-
loprotease and disintegrin domains. A comparison of the cDNA
and genomic sequences suggested the existence of a new exon.
This isoform was detected in murine dorsal root ganglion and
neuronal cell lines by RT-PCR. Overexpression of meltrin L
mini but not meltrin L induced neurite outgrowth in neuronal
cells. These studies suggest that the novel meltrin L isoform has
a distinct function related to neurogenesis.
* 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The metalloprotease-disintegrin meltrin L (ADAM19) be-
longs to the ADAM (a disintegrin and metalloprotease) fam-
ily. Its speci¢c patterns of expression during embryogenesis
suggest that it is involved in the development of the peripheral
nervous system, skeletal muscle, bone and heart tissue [1^3].
To date, more than 30 ADAMs have been identi¢ed in
worms, £ies, rodents, primates and humans [4,5]. ADAMs
are thought to be involved in numerous biological functions,
including fertilization, myogenesis, neurogenesis, and epitheli-
al tissue development [4,6,7]. Some ADAMs are catalytically
active metalloproteases and participate in the proteolytic pro-
cessing of the extracellular domains of membrane-anchored
proteins [8,9]. For example, TACE (ADAM17) is involved
in the processing of tumor necrosis factor-K in this manner
[10,11]. Another example is meltrin L (ADAM19), which has
been implicated in the processing of neuregulin L, another
membrane-anchored growth factor [12]. However, the metal-
loprotease domains of about half of the known ADAMs lack
a catalytic site, although the domain is otherwise highly con-
served. Protease-defective ADAMs also have an essential role
in murine development (ADAM2, 3, 23), indicating that
ADAMs function other than as proteases. Other studies sug-
gest that ADAMs are also involved in cell^cell or cell^extra-
cellular matrix interactions through their interaction with in-
tegrins [13^16] or proteoglycans [17]. Here, we report the
properties of meltrin L mini, a new splice variant of meltrin
L (ADAM19) that lacks the prodomain, metalloprotease and
disintegrin domains.
2. Materials and methods
2.1. Materials
Chemicals were purchased from Sigma (St. Louis, MO, USA) and
nacalai tesque (Kyoto, Japan). Restriction enzymes and molecular
biology reagents were purchased from TaKaRa (Kyoto, Japan) and
Toyobo (Osaka, Japan), unless otherwise indicated.
2.2. Isolation of L mini cDNA
An initial cDNA clone encompassing the disintegrin and cysteine-
rich domains of meltrin L was identi¢ed among RT-PCR products
ampli¢ed from murine myogenic cellular RNA [1]. This clone was
used as a probe to isolate cDNA clones encoding meltrin L and
L mini from a cDNA library prepared from a murine myoblast cell
line, C2, in V Zap II (Stratagene, La Jolla, CA, USA). Sequencing was
carried out by the dideoxy chain termination method using a dye
primer cycle sequencing kit (Applied Biosystems/Perkin Elmer, Foster
City, CA, USA) and an ABI 373A DNA sequencer (Applied Biosys-
tems/Perkin Elmer).
2.3. RT-PCR analysis
mRNA was extracted from murine embryos with the QuickPrep
micro mRNA Puri¢cation Kit (Amersham Pharmacia Biotech) and
used as a template for cDNA synthesis with the SuperScript First-
Strand Synthesis System (Invitrogen). PCR was carried out with Am-
pliTaq Gold DNA polymerase (PE Applied Biosystems) for 40 cycles
at 96‡C for 15 s, 62‡C for 30 s and 72‡C for 30 s. The primers used to
identify meltrin L mRNAs were 5P-CGCAGAATGAAACGGGAA-
GATCT-3P and 5P-TACACCAATGGCATTCTCGGAGTG-3P (for
meltrin L ; 421 bp) and 5P-CTTCAGAGCGAGTGTGGAGAG-3P
and 5P-AGAGTGCAGTTGGAGGGCATTG-3P (for L mini; 211
bp). The G3PDH 0.45 kb Control Amplimer Set (Clontech) was
used as a positive control. To determine the 3P-terminus of the alter-
natively spliced form of meltrin L, RT-PCR was carried out with
primer 1, speci¢c to the end of the meltrin L coding region (5P-TT-
CTCGACACTTCTAGATCTTGG-3P), and primer 2, speci¢c to se-
quences in the alternatively spliced form (5P-CTTCAGAGCGAGT-
GTGGAGAG-3P).
2.4. Plasmids
A cDNA sequence encoding the presumed L mini protein was con-
structed by ligating a L mini partial fragment to a meltrin L fragment
encoding the region from the cysteine-rich domain through the cyto-
plasmic tail. The E347Q protease-de¢cient meltrin L construct has
been previously described [12]. The plasmid pBIE was generated
by replacement of the human cytomegalovirus promoter region of
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pIRES2-EGFP (Clontech) with the promoter region of pEF-BOS [12].
All meltrin L constructs were inserted into pEF-BOS, which bears the
human EF-1K promoter [18].
2.5. Cell culture and neurite outgrowth
COS-7 cells or the murine neuroblastoma cell line N1E-115 were
maintained in Dulbecco’s modi¢ed Eagle’s medium (DMEM) contain-
ing 10% fetal bovine serum. The cells were transfected with Lipofect-
AMINE 2000 (Invitrogen) according to the manufacturer’s instruc-
tions. All constructs were transfected together with pBIE. For
neuronal di¡erentiation, N1E-115 cells were washed twice with phos-
phate-bu¡ered saline (PBS) at 4^6 h after transfection and then al-
lowed to di¡erentiate in DMEM. For quanti¢cation of neurite out-
growth, cells were allowed to di¡erentiate for 24 h after transfection,
and three to ¢ve random photographs were taken per well. Cells
bearing processes ¢ve times longer than the cell diameter were
Fig. 1. Alternatively spliced transcripts generated from the murine meltrin L gene. a: Schematic representation of a cDNA clone showing an al-
ternatively spliced transcript generated from the murine meltrin L gene. The white box represents an exon. The number above the box indicates
the exon number according to NCBI LocusLink (ID: 11492). 12A indicates a putative L mini-speci¢c exon. b: Predicted L mini cDNA, as de-
termined by RT-PCR. (Left) A 1.6 kb RT-PCR product generated by the primer set (1,2), as described in Section 2. (Right) Pro, prodomain;
MP, metalloprotease domain; Dis, disintegrin domain; Cys, cysteine-rich domain; ER, EGF-like repeat domain; TM, transmembrane domain;
Cp, cytoplasmic domain. The hatched box represents the L mini-speci¢c sequence derived from exon 12A. c: Domain organization of murine
meltrin L (upper) and L mini (lower) proteins. Numbers indicate meltrin L amino acid residues. d: Immunoblot analysis of meltrin L and
L mini proteins expressed in COS-7 cells. The cell lysates were prepared as described in Section 2 and subjected to immunoblot analysis with
an antibody speci¢c for the carboxy-terminus of meltrin L, which recognizes both the meltrin L and L mini proteins. Open and ¢lled triangles
indicate the V120 kDa prodomain-containing inactive form and the V100 kDa prodomain-excised active form of meltrin L, respectively.
Open and ¢lled circles also indicate the V60 kDa full-length form and the V40 kDa processed form of L mini, respectively. Prestained molec-
ular mass standards are shown on the right.
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counted as positive. The cells were analyzed under a immuno£uores-
cence microscope (Axiovert 200M; Zeiss) equipped with a Plan-Ach-
romat 20U lens. The images were acquired with Metamorph software.
2.6. Immunoblotting
Four to six hours after transfection, N1E-115 cells were di¡erenti-
ated in DMEM for 24 h. The cells were scraped from 60 mm dishes
with a rubber policeman and homogenized in 300 Wl 500 mM sodium
carbonate containing a protease inhibitor cocktail (25955-11, Nacalai
Tesque), pH 11.0, with a loosely ¢tting homogenizer. The homogenate
was sonicated with three 20 s pulses and the lysates were subjected to
immunoblot analysis. Primary antibodies were applied for 1 h in PBS
containing 5% skim milk at the following dilutions: anti-meltrin
L antiserum, 1:300; polyclonal anti-GAP-43 antibody (AB5220,
Chemicon), 1:5000; polyclonal anti-GFP antibody (598, MBL, Ja-
pan), 1:300. Immunoblots were developed using horseradish peroxi-
dase-conjugated secondary antibody (PI-1000, Vector) followed by
enhanced chemiluminescence. The intensity of each band was deter-
mined by laser densitometry of immunoblots using Molecular Dy-
namics Densitometer and ImageQuant software (Sunnyvale, CA,
USA). Scans of multiple exposures were made to ensure that the
results fell into the linear range of the instrument. For GAP-43 im-
munoblot analysis, the amount of protein loaded was normalized to
the level of GFP as a control.
3. Results
We used a meltrin L probe to screen a cDNA library de-
rived from the C2 myoblast cell line. Thirteen positive clones
were identi¢ed among 2.5U105 primary plaques. Analyses of
the inserts by restriction digestion and sequence analysis al-
lowed two independently isolated clones to be classi¢ed as
alternatively spliced forms of meltrin L. Both clones consisted
of novel V200 bp sequences followed by a truncated disinte-
grin domain and entire cysteine-rich domains of meltrin L
(amino acid residues 438^707) (Fig. 1b; supplemental data,
http://www.elsevier.com/PII/S0014579302037328). A search of
the mouse genome database revealed that a new exon encod-
ing the novel isoform-speci¢c sequence was located between
exons 12 and 13 of meltrin L.
To determine the 3P-terminus of the alternatively spliced
form of meltrin L, we designed PCR primers speci¢c to the
end of the meltrin L coding region and to sequences unique to
the alternatively spliced form. RT-PCR performed with these
primers yielded a 1.6 kb PCR product (Fig. 1b). Sequence
analysis of this PCR product revealed that it encoded amino
acid residues 438^920 of meltrin L (DDBJ accession number
AB096093). The ¢rst methionine (502) of this translated se-
quence lies just upstream of the cysteine-rich domain coding
region (Fig. 1c) and is preceded by a termination codon
downstream of the L mini-speci¢c exon; the deduced amino
acid sequence thus lacks the prodomain, metalloprotease and
disintegrin domains. When this clone was transiently ex-
pressed in COS-7 cells, V60 kDa and V40 kDa bands
were detected by immunoblot analysis with an antibody spe-
ci¢c to the meltrin L carboxy-terminus (Fig. 1d). These bands
were not detected in COS-7 cells transfected with meltrin L.
Together, these results indicate that this cDNA clone can
generate a novel alternatively spliced form of meltrin L as a
translation product, which we have named meltrin L mini
(L mini).
It has been reported that meltrin L is expressed in the dorsal
root ganglia (DRG) of murine embryos. L mini was also ex-
Fig. 2. Expression of L mini in the DRG and in N1E-115 cells.
L mini expression was detected in the DRG and in N1E-115 cells
by RT-PCR analysis. Lanes 1^4, DRG of E11.5, E13.5, E16.5 and
P1 embryos, respectively; lanes 5^7, N1E-115 cells analyzed 0, 1,
3 days after the induction of di¡erentiation, respectively.
Fig. 3. Neuritogenesis of N1E-115 cells is accelerated by the overex-
pression of L mini protein. a: Morphology of N1E-115 cells trans-
fected with cDNAs encoding the indicated constructs. All constructs
were transfected together with the EGFP expression vector. mini,
L mini; VT, EGFP expression vector alone; WT, wild type meltrin
L ; EQ, protease-de¢cient meltrin L. Scale bar, 50 Wm. b: Neuronal
di¡erentiation of N1E-115 cells. Cells with neurites ¢ve times longer
than the cell diameter were counted as positive. The percentage of
the total cells is shown. *P6 0.01 between the experimental groups.
c: Western blot analysis of GAP-43 protein levels in cells trans-
fected with the indicated cDNA constructs following di¡erentiation
for the indicated periods of time. Numbers under each lane show
the relative intensity of the bands against the control (0 DIV). DIV,
days in vitro.
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pressed in the DRG (from embryonic day (E) 11.5 through
postnatal day (P) 1) (Fig. 2). We also detected meltrin L and
L mini mRNAs in murine neuroblastoma N1E-115 cells,
which di¡erentiate into neuronal cells after serum depletion.
No major changes in the levels of meltrin L and L mini
mRNAs could be seen upon the induction of di¡erentiation.
The endogenous L mini protein could not be detected by
available anti-meltrin L antibodies, probably due to the low
level of L mini expression (data not shown).
We investigated the e¡ects of overexpression of L mini in
N1E-115 cells. After 24 h of di¡erentiation, N1E-115 cells
expressing L mini exhibited elaborate neurite-like structures
(Fig. 3a,b). Such morphological changes were never seen in
N1E-115 cells expressing either meltrin L or a protease-de¢-
cient meltrin L mutant (EQ). To determine whether L mini
augments neurite outgrowth as a result of di¡erentiation, we
examined the expression levels of GAP-43, a protein marker
for neuronal di¡erentiation [19], in transfected N1E-115 cells.
As shown in Fig. 3c, N1E-115 cells transfected with L mini
express more GAP-43 than control cells. Three days after
induction, however, the level of expression of GAP-43 and
the morphology of L mini-expressing cells were comparable
to those seen in cells transfected with other constructs. These
data suggest that L mini accelerates neurite outgrowth.
4. Discussion
Alternatively spliced forms of ADAM have previously been
reported. ADAM12-S, a secreted form of human ADAM12
(meltrin K), lacks the transmembrane domain and has a
unique 34 amino acid carboxy-terminus [20]. To our knowl-
edge, ours is the ¢rst report of an alternatively spliced form of
ADAM that encodes a protein lacking the prodomain, metal-
loprotease and disintegrin domains. An inspection of the pre-
sumed amino acid sequence indicates that L mini does not
have an obvious signal sequence, and we did not detect
L mini on the surface of transiently expressed COS-7 cells
(data not shown). Whether L mini is integrated as a mem-
brane protein or whether L mini protein is stably expressed
in vivo remains elusive. Fertilin L (ADAM2) is proteolytically
processed to a mature form that lacks the metalloprotease and
disintegrin domains and covalently associates with fertilin K
[21,22]. Although L mini is the product of alternative splicing
and not of post-translational processing, it has a domain
structure similar to that of the mature form of fertilin L.
We could not detect interaction of L mini with either meltrin
L or meltrin K by immunoprecipitation (data not shown), but
L mini may still be associated with other ADAMs. Although
the function of L mini is unknown, in vitro overexpression
studies suggested that this novel meltrin L isoform has roles
distinct from that of meltrin L, especially in neuritogenesis.
L mini-speci¢c knock-down experiments such as gene target-
ing or RNA interference assays are likely to reveal its in vivo
roles.
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